Bristol Takes $455 Mil. Litigation Charge, Higher Than Earlier Expectations

Bristol-Myers Squibb increased its litigation reserves to $455 mil. in the second quarter, a charge that is $55 mil. higher than earlier expectations

More from Archive

More from Pink Sheet